ABSTRACT

Bronchiolitis is an inflammatory disease of the peripherical airway, involving the terminal and respiratory bronchioles, in general this entity is present in a great variety of pulmonary disorders of known and unknown etiology. Bronchiolitis is divided in proliferative or inflammatory as well as constrictive or cicatrizal, the first one responds to therapy very well specially with anti-inflammatory drugs, however in the cicatrizal form progress can cause very serious respiratory changes associated with a worse prognosis; this revision is focused in the more frequent causes of bronchiolar damage like collagen vascular diseases, drugs, post infectious, and punctually over image methods specially the high resolution computed tomography (HRCT) where the tomography findings identify and suggest the diagnosis even without the morphological exam.

KEYWORDS

Bronchiolitis, collagen-vascular diseases, anti-inflammatory drugs, high resolution computed tomography (HRCT).

REFERENCES

1. Myers J, Colby T. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med 1993; 14: 611-622.

2. Epler G. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001; 161: 158-164.

3. Penn C, Liu Ch. Bronchiolitis following infection in adults and children. Clin Chest Med 1993; 14: 645-654.

4. Selman M, Chapela R, Raghu G. Hypersensitivity pneumonitis: Clinical manifestations, diagnosis, pathogenesis and therapeutic strategies. Sem Resp Med 1993; 14: 353.

5. Selman M, Pérez Padilla R. Airflow obstruction and airway lesions in hypersensitivity pneumonitis. Clin Chest Med 1993; 14: 699-714.

6. Green M, Turton CW. Bronchiolitis and its manifestations. Eur J Respir Dis Suppl. 1982; 121: 36-42.

7. Vergnenegre A, Pugnere N, Antonini MT, et al. Airway obstruction and rheumatoid arthritis. Eur Respir J 1997; 10: 1072-1078.

8. Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 1998; 157: 1658-1665.

9. Webb WR. Airway Disease: Bronchiectasis, chronic bronchitis and bronchiolitis. In: Webb WR, Higgins CB; eds. Thoracic Imaging. 1st Edition. 2005: 527-552.

10. Webb WR. Collagen-Vascular Diseases. In: Webb WR, Higgins CB eds. Thoracic Imaging. 1st Edition. 2005: 425-438.

11. Katzenstein ALA, Myers JL, Prophet DW, et al. Bronchiolitis obliterans and usual interstitial pneumonia. Am J Surg Pathol 1986; 10: 373-381.

12. Herzog CA, Miller RR, Hoidal JR. Bronchiolitis and rheumatoid arthritis. Am Rev Respir Dis 1981; 124: 636-639.

13. Cortot AB, Cottin V, Miossec P, et al. Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept. Respir Med 2005; 99: 511-514.

14. Yamamoto M, Ina Y, Kitaichi M, et al. Clinical features of BOOP in Japan. Chest 1992; 102(1 Suppl): 21S-25S.

15. Cohen AJ, King TE, Jr., Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 1994; 149: 1670-1675.

16. King TEJ. Connective tissue disease. In: Schwarz MI, King TE Jr, eds. Interstitial lung disease. 3rd ed. Hamilton, ON, Canada: BC Decker, 1998; 451-505.

17. Hayakawa H, Sato A, Imokawa S, et al. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med. Nov 1996; 154: 1531-1536.

18. Howling SJ, Hansell DM, Wells AU, et al. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology 1999; 212: 637-642.

19. Schwartz M. Lymphoplasmocytic infiltrations of the lung. In: Schwarz MI, King TE Jr, eds. interstitial lung disease. 3rd ed. Hamilton, ON, Canada: BC Decker 1998: 685-696.

20. Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjögren’s syndrome. Clin Chest Med 1998; 19: 687-699.

21. Eichacker PQ, Pinsker K, Epstein A, et al. Serial pulmonary function testing in patients with systemic lupus erythematosus. Chest 1988; 94: 129-132.

22. Kinney WW, Angelillo VA. Bronchiolitis in systemic lupus erythematosus. Chest 1982; 82(5): 646-649.

23. Godeau B, Cormier C, Menkes CJ. Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide. Ann Rheum Dis 1991; 50: 956-958.

24. Harrison NK, Myers AR, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144(3 Pt 1): 706-713.

25. Boehler A, Vogt P, Speich R, et al. Bronchiolitis obliterans in a patient with localized scleroderma treated with Dpenicillamine. Eur Respir J 1996; 9(6): 1317-1319.

26. Tomioka R, King TE, Jr. Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med 1997; 155(3): 1011-1020.

27. Winterbauer RH, Wilske KR, Wheelis RF. Diffuse pulmonary injury associated with gold treatment. N Engl J Med 1976; 294(17): 919-921.

28. Holness L, Tenenbaum J, Cooter NB, et al. Fatal bronchiolitis obliterans associated with chrysotherapy. Ann Rheum Dis 1983; 42(5): 593-596.

29. Turner-Warwick M. Adverse reactions affecting the lung: possible association with D-penicillamine. J Rheumatol Suppl. 1981; 7: 166-168.

30. Lahdensuo A, Mattila J, Vilppula A. Bronchiolitis in rheumatoid arthritis. Chest 1984; 85(5): 705-708.

31. Mason JW. Amiodarone. N Engl J Med 1987; 316(8): 455-466.

32. Martin WJ, 2nd, Rosenow EC, 3rd. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I). Chest 1988; 93(5): 1067-1075.

33. Oonakahara K, Matsuyama W, Higashimoto I, et al. Outbreak of Bronchiolitis obliterans associated with consumption of Sauropus androgynus in Japan-alert of food-associated pulmonary disorders from Japan. Respiration 2005; 72(2): 221.

34. Yang CF, Wu MT, Chiang AA, et al. Correlation of highresolution CT and pulmonary function in bronchiolitis obliterans: a study based on 24 patients associated with consumption of Sauropus androgynus. AJR Am J Roentgenol 1997; 168(4): 1045-1050.

35. Hartman TE, Primack SL, Lee KS, et al. CT of bronchial and bronchiolar diseases. Radiographics 1994; 14(5): 991-1003.

36. Stern EJ, Muller NL, Swensen SJ, et al. CT mosaic pattern of lung attenuation: etiologies and terminology. J Thorac Imaging Winter 1995; 10(4): 294-297.